| VRTX | Vertex Pharmaceuticals Inc | $121.26B | +1569625.03% |
| VRNA | Verona Pharma Plc | $77.75B | +1006378.15% |
| REGN | Regeneron Pharmaceuticals Inc | $69.10B | +894469.44% |
| ARGX | Argen X SE | $57.12B | +739389.97% |
| ALNY | Alnylam Pharmaceuticals Inc | $36.95B | +478254.37% |
| RVMD | Revolution Medicines Inc | $36.92B | +477859.65% |
| ONC | BeiGene Ltd | $36.03B | +466390.46% |
| MRNA | Moderna Inc | $27.11B | +350815.41% |
| ROIV | Roivant Sciences Ltd | $25.13B | +325260.17% |
| RPRX | Royalty Pharma plc - Class A | $24.60B | +318302.62% |
| INSM | Insmed Inc | $23.78B | +307695.32% |
| BNTX | BioNTech SE | $23.26B | +301048.59% |
| INCY | Incyte Corp | $23.01B | +297802.36% |
| GMAB | Genmab | $18.57B | +240286.79% |
| ASND | Ascendis Pharma A/S | $17.33B | +224227.95% |
| BBIO | BridgeBio Pharma Inc | $16.18B | +209321.73% |
| JAZZ | Jazz Pharmaceuticals plc | $14.81B | +191673.26% |
| EXEL | Exelixis Inc | $14.09B | +182341.93% |
| MDGL | Madrigal Pharmaceuticals Inc | $12.68B | +164033.45% |
| AXSM | Axsome Therapeutics Inc | $12.21B | +158014.87% |
| SMMT | Summit Therapeutics Inc | $11.69B | +151292.08% |
| BMRN | Biomarin Pharmaceutical Inc | $11.39B | +147390.53% |
| TECH | Bio-Techne Corp | $11.19B | +144731.14% |
| ABVX | Abivax | $10.86B | +140463.86% |
| KRYS | Krystal Biotech Inc | $10.31B | +133368.17% |
| CYTK | Cytokinetics Inc | $10.18B | +131747.40% |
| ARWR | Arrowhead Pharmaceuticals Inc | $10.10B | +130595.17% |
| APGE | Apogee Therapeutics Inc | $10.06B | +130079.27% |
| NUVL | Nuvalent Inc - Class A | $9.75B | +126144.13% |
| KYMR | Kymera Therapeutics Inc | $9.38B | +121310.83% |
| CORT | Corcept Therapeutics Inc | $9.35B | +120995.24% |
| IONS | Ionis Pharmaceuticals Inc | $9.08B | +117442.70% |
| HALO | Halozyme Therapeutics Inc | $8.99B | +116233.51% |
| PRAX | Praxis Precision Medicines Inc | $8.87B | +114739.76% |
| CRNX | Crinetics Pharmaceuticals Inc | $8.84B | +114284.32% |
| PTGX | Protagonist Therapeutics Inc | $8.70B | +112528.29% |
| TGTX | TG Therapeutics Inc | $8.64B | +111697.56% |
| PCVX | Vaxcyte Inc | $8.19B | +105903.25% |
| IMVT | Immunovant Inc | $8.13B | +105187.48% |
| IBRX | ImmunityBio Inc | $8.10B | +104705.98% |
| SYRE | Spyre Therapeutics Inc | $8.05B | +104074.73% |
| RYTM | Rhythm Pharmaceuticals Inc | $7.51B | +97091.37% |
| MTSR | Metsera Inc | $7.40B | +95756.74% |
| MIRM | Mirum Pharmaceuticals Inc | $7.37B | +95334.99% |
| MRUS | Merus N.V | $6.83B | +88261.82% |
| COGT | Cogent Biosciences Inc | $6.71B | +86782.48% |
| ACLX | Arcellx Inc | $6.67B | +86193.68% |
| XENE | Xenon Pharmaceuticals Inc | $6.54B | +84594.81% |
| PTCT | PTC Therapeutics Inc | $6.53B | +84491.24% |
| CDTX | Cidara Therapeutics Inc | $6.49B | +83971.49% |
| SRRK | Scholar Rock Holding Corp | $6.44B | +83221.92% |
| CGON | Cg Oncology Inc | $6.42B | +83069.15% |
| CNTA | Centessa Pharmaceuticals plc | $6.27B | +81023.20% |
| TERN | Terns Pharmaceuticals Inc | $5.95B | +76894.48% |
| LGND | Ligand Pharmaceuticals Inc - Class B | $5.93B | +76715.83% |
| BLTE | Belite Bio Inc | $5.88B | +76021.33% |
| ERAS | Erasca Inc | $5.51B | +71183.84% |
| DNTH | Dianthus Therapeutics Inc | $5.45B | +70496.44% |
| APLS | Apellis Pharmaceuticals Inc | $5.25B | +67846.73% |
| TVTX | Travere Therapeutics Inc | $5.24B | +67773.04% |
| CRSP | CRISPR Therapeutics AG | $4.95B | +63997.30% |
| CAI | Caris Life Sciences Inc - Class A | $4.94B | +63787.04% |
| FOLD | Amicus Therapeutics Inc | $4.50B | +58210.02% |
| ACAD | Acadia Pharmaceuticals Inc | $4.43B | +57307.47% |
| CELC | Celcuity Inc | $4.42B | +57174.33% |
| EWTX | Edgewise Therapeutics Inc | $4.39B | +56710.89% |
| VKTX | Viking Therapeutics Inc | $4.38B | +56626.48% |
| AKRO | Akero Therapeutics Inc | $4.38B | +56603.24% |
| TNGX | Tango Therapeutics Inc | $4.36B | +56354.20% |
| ORKA | ARCA biopharma Inc | $4.35B | +56174.35% |
| LEGN | Legend Biotech Corp | $4.26B | +54999.24% |
| DYN | Dyne Therapeutics Inc | $3.96B | +51205.30% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | +49707.63% |
| TLX | Telix Pharmaceuticals Ltd | $3.82B | +49413.95% |
| NAMS | NewAmsterdam Pharma Company NV | $3.73B | +48189.26% |
| RLAY | Relay Therapeutics Inc | $3.69B | +47687.96% |
| DNLI | Denali Therapeutics Inc | $3.65B | +47180.40% |
| ALMS | Alumis Inc | $3.60B | +46538.83% |
| GPCR | Structure Therapeutics Inc | $3.53B | +45551.75% |
| RCUS | Arcus Biosciences Inc | $3.52B | +45422.94% |
| ARQT | Arcutis Biotherapeutics Inc | $3.47B | +44868.31% |
| ELVN | Enliven Therapeutics Inc | $3.24B | +41803.17% |
| IDYA | Ideaya Biosciences Inc | $3.23B | +41685.90% |
| BEAM | Beam Therapeutics Inc | $3.17B | +40918.54% |
| RARE | Ultragenyx Pharmaceutical Inc | $3.12B | +40252.29% |
| VERA | Vera Therapeutics Inc - Class A | $3.04B | +39225.22% |
| IRON | Disc Medicine Inc | $2.90B | +37483.85% |
| MBX | MBX Biosciences Inc | $2.89B | +37265.05% |
| SLNO | Soleno Therapeutics Inc | $2.74B | +35391.08% |
| KOD | Kodiak Sciences Inc | $2.64B | +34032.64% |
| IMNM | Immunome Inc | $2.59B | +33479.15% |
| QURE | uniQure N.V. | $2.58B | +33355.84% |
| CLDX | Celldex Therapeutics Inc | $2.55B | +32914.32% |
| TARS | Tarsus Pharmaceuticals Inc | $2.47B | +31923.58% |
| NRIX | Nurix Therapeutics Inc | $2.47B | +31917.83% |
| MLYS | Mineralys Therapeutics Inc | $2.43B | +31380.81% |
| VCEL | Vericel Corp | $2.38B | +30751.52% |
| AGIO | Agios Pharmaceuticals Inc | $2.37B | +30528.24% |
| MESO | Mesoblast Ltd | $2.36B | +30408.58% |
| ETNB | 89bio Inc | $2.34B | +30230.53% |
| TRVI | Trevi Therapeutics Inc | $2.33B | +30063.23% |
| SLS | SELLAS Life Sciences Group Inc | $2.32B | +29923.74% |
| PHVS | Pharvaris NV | $2.30B | +29624.56% |
| ZLAB | Zai Lab Ltd | $2.27B | +29277.40% |
| BHVN | Biohaven Ltd | $2.24B | +28872.41% |
| DAWN | Day One Biopharmaceuticals Inc | $2.22B | +28602.96% |
| OCUL | Ocular Therapeutix Inc | $2.18B | +28123.92% |
| PVLA | Palvella Therapeutics Inc | $2.18B | +28059.63% |
| AUPH | Aurinia Pharmaceuticals Inc | $2.11B | +27155.60% |
| SNDX | Syndax Pharmaceuticals Inc | $2.08B | +26859.65% |
| IOVA | Iovance Biotherapeutics Inc | $2.08B | +26782.92% |
| ABCL | AbCellera Biologics Inc | $2.05B | +26420.04% |
| NUVB | Nuvation Bio Inc - Class A | $2.04B | +26365.39% |
| HRMY | Harmony Biosciences Holdings Inc | $2.02B | +26044.34% |
| ADMA | Adma Biologics Inc | $2.02B | +26001.58% |
| SION | Sionna Therapeutics Inc | $2.00B | +25796.90% |
| GLUE | Monte Rosa Therapeutics Inc | $1.97B | +25454.02% |
| ATAI | ATAI Life Sciences N.V. | $1.96B | +25265.61% |
| VRDN | Viridian Therapeutics Inc | $1.95B | +25180.61% |
| URGN | UroGen Pharma Ltd | $1.94B | +24995.99% |
| TYRA | Tyra Biosciences Inc | $1.93B | +24828.20% |
| NBTX | Nanobiotix | $1.91B | +24637.17% |
| RAPP | Rapport Therapeutics Inc | $1.91B | +24612.31% |
| GLPG | Galapagos NV | $1.90B | +24474.00% |
| AAPG | Ascentage Pharma Group International | $1.87B | +24091.60% |
| STOK | Stoke Therapeutics Inc | $1.86B | +23999.43% |
| SRPT | Sarepta Therapeutics Inc | $1.86B | +23967.06% |
| BCAX | Bicara Therapeutics Inc | $1.84B | +23756.66% |
| ZBIO | Zenas Biopharma Inc | $1.83B | +23651.02% |
| PGEN | Precigen Inc | $1.82B | +23489.63% |
| ZYME | Zymeworks BC Inc | $1.80B | +23236.99% |
| TSHA | Taysha Gene Therapies Inc | $1.78B | +22920.23% |
| IMCR | Immunocore Holdings plc | $1.76B | +22720.97% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | $1.76B | +22637.21% |
| FTRE | Fortrea Holdings Inc | $1.69B | +21833.36% |
| NKTR | Nektar Therapeutics | $1.69B | +21771.06% |
| MPLT | MapLight Therapeutics Inc | $1.69B | +21747.44% |
| GHRS | GH Research PLC | $1.67B | +21518.40% |
| ANAB | AnaptysBio Inc | $1.62B | +20878.14% |
| INVA | Innoviva Inc | $1.62B | +20815.47% |
| NTLA | Intellia Therapeutics Inc | $1.57B | +20232.64% |
| RAPT | RAPT Therapeutics Inc | $1.56B | +20151.91% |
| VIR | Vir Biotechnology Inc | $1.55B | +19958.51% |
| SEPN | Septerna Inc | $1.53B | +19710.58% |
| AVBP | ArriVent BioPharma Inc | $1.49B | +19226.70% |
| ABSI | Absci Corp | $1.49B | +19226.42% |
| MAZE | Maze Therapeutics Inc | $1.46B | +18823.57% |
| MLTX | MoonLake Immunotherapeutics - Class A | $1.42B | +18316.54% |
| NVAX | Novavax Inc | $1.39B | +17843.51% |
| KALV | KalVista Pharmaceuticals Inc | $1.38B | +17808.95% |
| INBX | Inhibrx Biosciences Inc | $1.33B | +17149.56% |
| ARDX | Ardelyx Inc | $1.31B | +16845.11% |
| IMTX | Immatics N.V | $1.28B | +16406.63% |
| MNKD | Mannkind Corp | $1.26B | +16255.73% |
| ANNX | Annexon Inc | $1.26B | +16241.10% |
| CRVS | Corvus Pharmaceuticals Inc | $1.25B | +16141.79% |
| TRML | Tourmaline Bio Inc | $1.24B | +15897.06% |
| SVRA | Savara Inc | $1.19B | +15312.87% |
| CAPR | Capricor Therapeutics Inc | $1.17B | +15091.22% |
| EYPT | EyePoint Pharmaceuticals Inc | $1.16B | +14862.71% |
| ORIC | ORIC Pharmaceuticals Inc | $1.15B | +14824.06% |
| WVE | Wave Life Sciences Ltd | $1.14B | +14615.33% |
| XNCR | Xencor Inc | $1.11B | +14262.74% |
| DRTS | Alpha Tau Medical Ltd | $1.10B | +14096.04% |
| CGEM | Cullinan Oncology Inc | $1.10B | +14084.09% |
| JBIO | Jade Biosciences Inc | $1.08B | +13864.33% |
| CVAC | CureVac N.V. | $1.05B | +13483.77% |
| OLMA | Olema Pharmaceuticals Inc | $1.03B | +13263.31% |
| MGTX | MeiraGTx Holdings plc | $1.02B | +13142.76% |
| KURA | Kura Oncology Inc | $1.01B | +12919.08% |
| VTYX | Ventyx Biosciences Inc | $998.72M | +12828.88% |
| GRCL | Gracell Biotechnologies Inc | $989.87M | +12714.31% |
| VOR | Vor Biopharma Inc | $979.68M | +12582.37% |
| JANX | Janux Therapeutics Inc | $975.67M | +12530.57% |
| ANRO | Alto Neuroscience Inc | $973.06M | +12496.79% |
| SANA | Sana Biotechnology Inc | $957.85M | +12299.84% |
| GERN | Geron Corp | $950.51M | +12204.85% |
| SLDB | Solid Biosciences Inc | $946.56M | +12153.64% |
| PHAR | Pharming Group N.V. | $939.88M | +12067.22% |
| LXRX | Lexicon Pharmaceuticals Inc | $936.56M | +12024.21% |
| DBVT | DBV Technologies | $930.17M | +11941.44% |
| LBRX | LB Pharmaceuticals Inc | $922.18M | +11838.10% |
| ABUS | Arbutus Biopharma Corp | $898.08M | +11526.11% |
| PHAT | Phathom Pharmaceuticals Inc | $877.84M | +11264.04% |
| TBPH | Theravance Biopharma Inc | $872.15M | +11190.39% |
| DSGN | Design Therapeutics Inc | $844.21M | +10828.69% |
| REPL | Replimune Group Inc | $800.70M | +10265.45% |
| ACRS | Aclaris Therapeutics Inc | $782.06M | +10024.10% |
| OCS | Oculis Holding AG | $772.84M | +9904.76% |
| ZVRA | Zevra Therapeutics Inc | $766.13M | +9817.91% |
| CMRX | Chimerix Inc | $766.03M | +9816.63% |
| RIGL | Rigel Pharmaceuticals | $758.21M | +9715.35% |
| SPRY | ARS Pharmaceuticals Inc | $749.72M | +9605.44% |
| OMER | Omeros Corporation | $746.63M | +9565.44% |
| MNPR | Monopar Therapeutics Inc | $728.12M | +9325.88% |
| DRUG | Bright Minds Biosciences Inc | $728.06M | +9325.10% |
| ATXS | Astria Therapeutics Inc | $709.95M | +9090.66% |
| CADL | Candel Therapeutics Inc | $706.21M | +9042.18% |
| XOMA | XOMA Royalty Corp | $699.64M | +8957.19% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | $673.55M | +8619.41% |
| CLYM | Eliem Therapeutics Inc | $662.55M | +8477.03% |
| CRMD | CorMedix Inc | $660.09M | +8445.17% |
| IVA | Inventiva | $655.21M | +8382.07% |
| CTMX | CytomX Therapeutics Inc | $652.36M | +8345.18% |
| RLMD | Relmada Therapeutics Inc | $651.37M | +8332.28% |
| MDXG | Mimedx Group Inc | $635.94M | +8132.51% |
| RGNX | Regenxbio Inc | $633.34M | +8098.90% |
| PRME | Prime Medicine Inc | $630.35M | +8060.16% |
| NGNE | Neoleukin Therapeutics Inc | $616.04M | +7874.97% |
| TECX | AvroBio Inc | $611.99M | +7822.50% |
| FDMT | 4D Molecular Therapeutics Inc | $610.53M | +7803.65% |
| GYRE | Gyre Therapeutics Inc | $599.17M | +7656.57% |
| IMMX | Immix Biopharma Inc | $558.22M | +7126.40% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | $555.56M | +7092.04% |
| CTNM | Contineum Therapeutics Inc - Class A | $546.27M | +6971.73% |
| ARVN | Arvinas Inc | $534.06M | +6813.67% |
| NVCT | Nuvectis Pharma Inc | $519.64M | +6626.93% |
| STTK | Shattuck Labs Inc | $511.69M | +6524.06% |
| ZURA | Zura Bio Ltd - Class A | $511.41M | +6520.41% |
| VSTM | Verastem Inc | $503.34M | +6415.99% |
| SLN | Silence Therapeutics Plc | $493.60M | +6289.91% |
| OCGN | Ocugen Inc | $483.80M | +6162.98% |
| KYTX | Kyverna Therapeutics Inc | $470.94M | +5996.58% |
| ALLO | Allogene Therapeutics Inc | $465.15M | +5921.61% |
| SVA | Sinovac Biotech Ltd | $464.94M | +5918.86% |
| CABA | Cabaletta Bio Inc | $463.15M | +5895.70% |
| RZLT | Rezolute Inc | $456.43M | +5808.65% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | $451.41M | +5743.74% |
| EVMN | Evommune Inc | $447.71M | +5695.80% |
| PRTA | Prothena Corporation plc | $447.44M | +5692.34% |
| BNTC | Benitec Biopharma Inc | $447.29M | +5690.43% |
| VALN | Valneva SE | $440.98M | +5608.68% |
| CBIO | N/A | $432.05M | +5493.13% |
| STRO | Sutro Biopharma Inc | $430.74M | +5476.10% |
| AURA | Aura Biosciences Inc | $430.49M | +5472.89% |
| PBYI | Puma Biotechnology Inc | $427.89M | +5439.30% |
| ASMB | Assembly Biosciences Inc | $424.80M | +5399.28% |
| OVID | Ovid Therapeutics Inc | $416.49M | +5291.71% |
| ABEO | Abeona Therapeutics Inc | $414.56M | +5266.63% |
| DMAC | DiaMedica Therapeutics Inc | $411.67M | +5229.25% |
| CYBN | Cybin Inc | $408.43M | +5187.35% |
| AVTX | Avalo Therapeutics Inc | $403.76M | +5126.91% |
| AUTL | Autolus Therapeutics plc | $401.88M | +5102.49% |
| RCKT | Rocket Pharmaceuticals Inc | $398.30M | +5056.21% |
| LRMR | Larimar Therapeutics Inc | $395.79M | +5023.75% |
| UPB | Upstream Bio Inc | $395.63M | +5021.67% |
| CCCC | C4 Therapeutics Inc | $395.34M | +5017.84% |
| IPSC | Century Therapeutics Inc | $390.82M | +4959.38% |
| YMAB | Y-Mabs Therapeutics Inc | $390.19M | +4951.18% |
| AVIR | Atea Pharmaceuticals Inc | $388.93M | +4934.91% |
| CMPX | Compass Therapeutics Inc | $385.39M | +4889.04% |
| ENTA | Enanta Pharmaceuticals Inc | $384.48M | +4877.24% |
| RVNC | Revance Therapeutics Inc | $380.38M | +4824.17% |
| PRTC | PureTech Health plc American Depositary Shares | $376.98M | +4780.24% |
| ALT | Altimmune Inc | $373.67M | +4737.40% |
| TENX | Tenax Therapeutics Inc | $372.39M | +4720.72% |
| PRLD | Prelude Therapeutics Inc | $368.04M | +4664.45% |
| XFOR | X4 Pharmaceuticals Inc | $367.85M | +4661.96% |
| FENC | Fennec Pharmaceuticals Inc | $366.13M | +4639.79% |
| VNDA | Vanda Pharmaceuticals Inc | $351.79M | +4454.09% |
| LXEO | Lexeo Therapeutics Inc | $351.17M | +4446.08% |
| EDIT | Editas Medicine Inc | $349.39M | +4422.96% |
| FATE | Fate Therapeutics Inc | $347.65M | +4400.56% |
| FBRX | Forte Biosciences Inc | $340.15M | +4303.43% |
| ZNTL | Zentalis Pharmaceuticals Inc | $340.13M | +4303.10% |
| PALI | Palisade Bio Inc | $339.87M | +4299.73% |
| IMAB | I-Mab | $339.64M | +4296.75% |
| EPRX | Eupraxia Pharmaceuticals Inc | $338.64M | +4283.91% |
| IMRX | Immuneering Corp Class A | $333.64M | +4219.13% |
| LYEL | Lyell Immunopharma Inc | $332.66M | +4206.48% |
| FHTX | Foghorn Therapeutics Inc | $319.97M | +4042.20% |
| INDP | Indaptus Therapeutics Inc | $319.34M | +4034.06% |
| ANL | Adlai Nortye Ltd | $317.46M | +4009.62% |
| GALT | Galectin Therapeutics Inc | $313.48M | +3958.14% |
| LCTX | Lineage Cell Therapeutics Inc | $305.39M | +3853.43% |
| VTVT | vTv Therapeutics Inc - Class A | $305.06M | +3849.15% |
| ELDN | Eledon Pharmaceuticals Inc | $304.92M | +3847.39% |
| SCPH | scPharmaceuticals Inc | $304.59M | +3843.07% |
| ARTV | Artiva Biotherapeutics Inc | $302.86M | +3820.69% |
| OABI | OmniAb Inc | $301.15M | +3798.54% |
| BCYC | Bicycle Therapeutics Plc | $294.16M | +3708.09% |
| NMRA | Neumora Therapeutics Inc | $293.19M | +3695.51% |
| GLSI | Greenwich LifeSciences Inc | $286.57M | +3609.83% |
| TTRX | Turn Therapeutics Inc | $285.37M | +3594.25% |
| CLLS | Cellectis | $282.48M | +3556.86% |
| TRDA | Entrada Therapeutics Inc | $276.01M | +3473.14% |
| NAGE | Niagen Bioscience Inc | $275.72M | +3469.28% |
| MGNX | Macrogenics Inc | $274.58M | +3454.57% |
| SABS | SAB Biotherapeutics Inc | $274.20M | +3449.59% |
| ALXO | Alx Oncology Holdings Inc | $273.12M | +3435.64% |
| IKT | Inhibikase Therapeutics Inc | $271.99M | +3421.01% |
| SRZN | Surrozen Inc | $250.37M | +3141.12% |
| IRD | Ocuphire Pharma Inc | $248.48M | +3116.70% |
| RNAC | Cartesian Therapeutics Inc | $247.77M | +3107.48% |
| THRD | Third Harmonic Bio Inc | $241.86M | +3031.05% |
| FULC | Fulcrum Therapeutics Inc | $237.12M | +2969.70% |
| GNFT | GENFIT S.A. American Depositary Shares | $233.01M | +2916.45% |
| ACIU | AC Immune SA | $232.87M | +2914.60% |
| AVXL | Anavex Life Sciences Corporation | $231.68M | +2899.20% |
| IVVD | Invivyd Inc | $231.05M | +2891.06% |
| QTTB | Q32 Bio Inc | $229.68M | +2873.35% |
| SLRN | Acelyrin Inc | $228.54M | +2858.62% |
| DTIL | Precision Biosciences Inc | $227.35M | +2843.16% |
| TARA | Protara Therapeutics Inc | $226.83M | +2836.41% |
| CGEN | Compugen Ltd | $223.15M | +2788.73% |
| CHRS | Coherus Biosciences Inc | $222.07M | +2774.85% |
| NAUT | Nautilus Biotechnology Inc | $221.10M | +2762.28% |
| CAMP | CAMP4 Therapeutics Corp | $218.61M | +2729.98% |
| KROS | Keros Therapeutics Inc | $217.65M | +2717.63% |
| ADAG | Adagene Inc | $217.38M | +2714.11% |
| SLGL | Sol-Gel Technologies Ltd | $215.10M | +2684.63% |
| KPTI | Karyopharm Therapeutics Inc | $214.84M | +2681.26% |
| OBIO | Orchestra BioMed Holdings Inc | $214.00M | +2670.36% |
| RNA | Atrium Therapeutics Inc | $210.40M | +2623.72% |
| IMUX | Immunic Inc | $205.68M | +2562.68% |
| TLSA | Tiziana Life Sciences Ltd | $201.81M | +2512.48% |
| CDXS | Codexis Inc | $200.88M | +2500.43% |
| NKTX | Nkarta Inc | $197.53M | +2457.07% |
| AGEN | Agenus Inc | $192.99M | +2398.40% |
| VYGR | Voyager Therapeutics Inc | $192.99M | +2398.40% |
| NERV | Minerva Neurosciences Inc | $189.40M | +2351.84% |
| KRRO | Korro Bio Inc | $187.93M | +2332.80% |
| PRQR | ProQR Therapeutics N.V | $186.49M | +2314.22% |
| PLX | Protalix BioTherapeutics Inc | $186.05M | +2308.48% |
| TNYA | Tenaya Therapeutics Inc | $182.97M | +2268.68% |
| MDWD | MediWound Ltd | $182.55M | +2263.25% |
| IFRX | InflaRx N.V. | $182.18M | +2258.38% |
| WHWK | Whitehawk Therapeutics Inc | $181.71M | +2252.28% |
| ARCT | Arcturus Therapeutics Holdings Inc | $181.62M | +2251.20% |
| SGMT | Sagimet Biosciences Inc - Class A | $180.81M | +2240.69% |
| ACOG | Alpha Cognition Inc | $180.73M | +2239.57% |
| MENS | Jyong Biotech Ltd | $174.10M | +2153.86% |
| ACHV | Achieve Life Sciences Inc | $173.54M | +2146.60% |
| PEPG | PepGen Inc | $168.86M | +2085.95% |
| ANTX | AN2 Therapeutics Inc | $168.05M | +2075.52% |
| CRBU | Caribou Biosciences Inc | $167.73M | +2071.29% |
| THTX | Theratechnologies Inc | $167.34M | +2066.25% |
| ALEC | Alector Inc | $166.54M | +2055.91% |
| ORMP | Oramed Pharmaceuticals Inc | $166.16M | +2051.02% |
| EQ | Equillium Inc | $165.65M | +2044.47% |
| TNXP | Tonix Pharmaceuticals Holding Corp | $164.92M | +2035.03% |
| IPHA | Innate Pharma | $164.54M | +2030.07% |
| OTLK | Outlook Therapeutics Inc | $163.20M | +2012.68% |
| YDES | YD Bio Ltd | $160.69M | +1980.23% |
| ABOS | Acumen Pharmaceuticals Inc | $160.35M | +1975.75% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | $159.83M | +1969.04% |
| LENZ | LENZ Therapeutics Inc | $156.46M | +1925.43% |
| PYXS | Pyxis Oncology Inc | $152.68M | +1876.52% |
| CNTB | Connect Biopharma Holdings Ltd | $152.39M | +1872.76% |
| HUMA | Humacyte Inc | $151.33M | +1859.02% |
| MIST | Milestone Pharmaceuticals Inc | $149.60M | +1836.63% |
| NBP | NovaBridge Biosciences. | $149.30M | +1832.73% |
| NRXP | NRX Pharmaceuticals Inc | $149.28M | +1832.53% |
| AKTX | Akari Therapeutics Plc | $148.12M | +1817.54% |
| MOLN | Molecular Partners AG | $146.63M | +1798.26% |
| ARMP | Armata Pharmaceuticals Inc | $146.49M | +1796.34% |
| AARD | Aardvark Therapeutics Inc | $145.52M | +1783.77% |
| MRSN | Mersana Therapeutics Inc | $145.36M | +1781.71% |
| HURA | TuHURA Biosciences Inc | $144.96M | +1776.57% |
| GUTS | Fractyl Health Inc | $144.37M | +1768.95% |
| PROK | ProKidney Corp - Class A | $137.85M | +1684.54% |
| TCRX | Tscan Therapeutics Inc | $137.63M | +1681.64% |
| CBUS | Cibus Global Ltd. Class A | $135.62M | +1655.68% |
| THAR | Tharimmune Inc | $135.41M | +1652.93% |
| SEER | Seer Inc - Class A | $132.16M | +1610.91% |
| GNLX | Genelux Corp | $130.49M | +1589.20% |
| VXRT | Vaxart Inc | $127.95M | +1556.37% |
| ENGN | enGene Holdings Inc | $127.28M | +1547.70% |
| UNCY | Unicycive Therapeutics Inc | $126.69M | +1540.11% |
| PMN | ProMIS Neurosciences Inc | $125.59M | +1525.86% |
| FBIO | Fortress Biotech Inc | $123.12M | +1493.88% |
| RANI | Rani Therapeutics Holdings Inc Class A | $121.86M | +1477.50% |
| VANI | Vivani Medical Inc | $119.35M | +1445.09% |
| ANIX | Anixa Biosciences Inc | $118.73M | +1437.01% |
| ALDX | Aldeyra Therapeutics Inc | $115.82M | +1399.30% |
| SAVA | Cassava Sciences Inc. | $114.97M | +1388.38% |
| RPTX | Repare Therapeutics Inc | $113.91M | +1374.65% |
| COYA | Coya Therapeutics Inc | $113.53M | +1369.74% |
| KLRS | Kalaris Therapeutics Inc | $110.82M | +1334.66% |
| ONCY | Oncolytics Biotech Inc | $104.98M | +1259.02% |
| HLVX | HilleVax Inc | $104.74M | +1255.90% |
| BDTX | Black Diamond Therapeutics Inc | $103.72M | +1242.66% |
| ADVM | Adverum Biotechnologies Inc | $102.40M | +1225.66% |
| SPRO | Spero Therapeutics Inc | $98.42M | +1174.04% |
| KZIA | Kazia Therapeutics Ltd | $97.74M | +1165.30% |
| VRCA | Verrica Pharmaceuticals Inc | $97.23M | +1158.71% |
| ICCC | Immucell Corp | $97.07M | +1156.65% |
| PYPD | Polypid Ltd | $94.84M | +1127.79% |
| BMEA | Biomea Fusion Inc | $93.27M | +1107.38% |
| CUE | Cue Biopharma Inc | $92.75M | +1100.63% |
| ENLV | Enlivex Ltd | $92.47M | +1097.03% |
| PTHS | Channel Therapeutics Corporation | $91.66M | +1086.60% |
| MAIA | MAIA Biotechnology Inc | $89.19M | +1054.57% |
| NTHI | NeOnc Technologies Holdings Inc | $87.88M | +1037.67% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | $86.99M | +1026.13% |
| CRDF | Cardiff Oncology Inc | $85.46M | +1006.35% |
| RLYB | Rallybio Corp | $85.33M | +1004.66% |
| CGTX | Cognition Therapeutics Inc | $84.81M | +997.85% |
| LPTX | Leap Therapeutics Inc | $84.76M | +997.24% |
| ATHE | Alterity Therapeutics Ltd | $84.66M | +995.98% |
| ACET | Adicet Bio Inc | $83.31M | +978.46% |
| HRTX | Heron Therapeutics Inc | $83.25M | +977.77% |
| ENTX | Entera Bio Ltd | $82.99M | +974.31% |
| INO | Inovio Pharmaceuticals Inc | $81.63M | +956.80% |
| CSBR | Champions Oncology Inc | $80.27M | +939.08% |
| NRXS | Neuraxis Inc | $79.92M | +934.62% |
| FBIOP | Fortress Biotech Inc | $77.72M | +906.12% |
| ATHA | Athira Pharma Inc | $77.21M | +899.58% |
| PMVP | PMV Pharmaceuticals Inc | $74.66M | +866.57% |
| GLTO | Galecto Inc | $74.66M | +866.45% |
| ACRV | Acrivon Therapeutics Inc | $74.39M | +863.02% |
| ATRA | Atara Biotherapeutics Inc | $72.78M | +842.14% |
| MNMD | Mind Medicine (MindMed) Inc. Common Shares | $71.93M | +831.12% |
| GANX | Gain Therapeutics Inc | $71.38M | +824.06% |
| XBIT | XBiotech Inc | $69.82M | +803.81% |
| PLRX | Pliant Therapeutics Inc | $69.34M | +797.70% |
| HYFT | MindWalk Holdings Corp | $69.31M | +797.23% |
| MNOV | Medicinova Inc | $68.91M | +792.07% |
| SPRB | Spruce Biosciences Inc | $67.96M | +779.71% |
| IMA | Ikena Oncology Inc | $67.49M | +773.71% |
| ELTX | Elicio Therapeutics Inc | $65.05M | +742.15% |
| IMMP | Immutep Ltd | $64.23M | +731.49% |
| KLTO | Klotho Neurosciences Inc Com | $63.55M | +722.73% |
| ACHL | Achilles Therapeutics Plc | $63.22M | +718.41% |
| EDSA | Edesa Biotech Inc | $61.04M | +690.26% |
| OSTX | OS Therapies Inc | $60.88M | +688.14% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | $59.20M | +666.37% |
| IBIO | iBio Inc | $58.38M | +655.74% |
| CNTX | Context Therapeutics Inc | $57.91M | +649.69% |
| OKYO | OKYO Pharma Ltd - New | $56.13M | +626.66% |
| BOLD | Boundless Bio Inc | $55.35M | +616.47% |
| INMB | INmune Bio Inc | $55.03M | +612.41% |
| CING | Cingulate Inc | $54.66M | +607.59% |
| KZR | Kezar Life Sciences Inc | $53.76M | +595.94% |
| INKT | MiNK Therapeutics Inc | $53.21M | +588.80% |
| XLO | Xilio Therapeutics Inc | $52.74M | +582.70% |
| MREO | Mereo Biopharma Group Plc | $52.58M | +580.70% |
| ATYR | Atyr Pharma Inc | $52.39M | +578.20% |
| MCRB | Seres Therapeutics Inc | $52.28M | +576.77% |
| BYSI | BeyondSpring Inc | $52.22M | +576.04% |
| EXOZ | Invizyne Technologies Inc | $51.89M | +571.76% |
| RNTX | Rein Therapeutics Inc | $51.79M | +570.50% |
| TIL | Instil Bio Inc | $51.68M | +569.01% |
| ANVS | Annovis Bio Inc | $51.65M | +568.67% |
| GOSS | Gossamer Bio Inc | $51.14M | +562.04% |
| IBO | Impact BioMedical Inc | $50.13M | +548.91% |
| MGX | Metagenomi Inc | $48.56M | +528.69% |
| DWTX | Virios Therapeutics Inc | $48.10M | +522.66% |
| LVTX | LAVA Therapeutics NV | $45.77M | +492.53% |
| TELO | Telomir Pharmaceuticals Inc | $45.73M | +491.95% |
| DYAI | Dyadic International Inc DE | $44.46M | +475.49% |
| PDSB | PDS Biotechnology Corporation | $41.64M | +439.03% |
| APLM | Apollomics Inc - Class A | $41.33M | +435.06% |
| ACTU | Actuate Therapeutics Inc | $40.78M | +427.97% |
| FGEN | FibroGen Inc | $39.31M | +408.84% |
| GRCE | Acasti Pharma Inc | $38.94M | +404.08% |
| VERU | Veru Inc | $38.84M | +402.83% |
| RNXT | RenovoRx Inc | $38.73M | +401.34% |
| NNVC | NanoViricides Inc | $37.23M | +381.99% |
| NTRB | Nutriband Inc | $37.08M | +379.96% |
| RADX | Radiopharm Theranostics Ltd | $36.10M | +367.40% |
| GBIO | Generation Bio Company | $35.97M | +365.63% |
| GNTA | Genenta Science SpA | $35.85M | +364.11% |
| ALGS | Aligos Therapeutics Inc | $35.71M | +362.23% |
| MURA | Mural Oncology plc | $35.34M | +357.53% |
| LTRN | Lantern Pharma Inc | $34.89M | +351.66% |
| LITS | Lite Strategy Inc | $34.77M | +350.15% |
| HYPD | Eyenovia Inc | $34.51M | +346.80% |
| LSTA | Lisata Therapeutics Inc | $34.15M | +342.12% |
| ABVC | ABVC BioPharma Inc | $32.98M | +326.98% |
| ESLA | Estrella Immunopharma Inc | $32.50M | +320.79% |
| SNTI | Senti Biosciences Inc | $32.39M | +319.31% |
| DARE | Dare Bioscience Inc | $30.14M | +290.15% |
| SER | AgeX Therapeutics Inc | $29.05M | +276.11% |
| SGMO | Sangamo Therapeutics Inc | $28.83M | +273.24% |
| BCTX | BriaCell Therapeutics Corp - New | $28.57M | +269.81% |
| ATNM | Actinium Pharmaceuticals Inc | $28.56M | +269.73% |
| CRVO | CervoMed Inc | $28.42M | +267.97% |
| PSTV | Plus Therapeutics Inc | $28.00M | +262.44% |
| TVRD | Cara Therapeutics Inc | $27.49M | +255.84% |
| BRNS | Barinthus Biotherapeutics Plc. | $26.44M | +242.25% |
| IGC | IGC Pharma Inc | $26.36M | +241.23% |
| EVAX | Evaxion Biotech A/S | $25.44M | +229.30% |
| VYNE | VYNE Therapeutics Inc | $25.25M | +226.94% |
| GRDX | Entero Therapeutics Inc | $24.74M | +220.25% |
| NXTC | Nextcure Inc | $23.92M | +209.63% |
| MRKR | Marker Therapeutics Inc | $23.55M | +204.83% |
| NRSN | NeuroSense Therapeutics Ltd | $23.41M | +202.99% |
| CELU | Celularity Inc - Class A | $22.49M | +191.19% |
| COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $21.96M | +184.23% |
| OPT | Opthea Ltd | $21.53M | +178.71% |
| SKYE | Skye Bioscience Inc | $21.29M | +175.61% |
| PLRZ | Polyrizon Ltd | $21.02M | +172.11% |
| ATOS | Atossa Therapeutics Inc | $21.01M | +172.01% |
| PHXM | PHAXIAM Therapeutics SA ADR | $20.38M | +163.78% |
| TVGN | Tevogen Bio Holdings Inc | $19.93M | +157.96% |
| SNSE | Sensei Biotherapeutics Inc | $19.48M | +152.11% |
| JSPR | Jasper Therapeutics Inc | $19.37M | +150.80% |
| KALA | Kala Bio Inc | $19.15M | +147.87% |
| NEUP | Neuphoria Therapeutics Inc | $18.93M | +145.03% |
| NCEL | NLS Pharmaceutics Ltd | $18.85M | +144.08% |
| ALLR | Allarity Therapeutics Inc | $18.67M | +141.65% |
| ICU | SeaStar Medical Holding Corp | $18.45M | +138.86% |
| PLUR | Pluri Inc | $18.25M | +136.31% |
| LPCN | Lipocine Inc | $17.64M | +128.37% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | $17.55M | +127.24% |
| HOWL | Werewolf Therapeutics Inc | $16.50M | +113.58% |
| HIND | ReShape Lifesciences Inc | $15.93M | +106.25% |
| PTN | Palatin Technologies Inc | $15.81M | +104.65% |
| PASG | Passage Bio Inc | $15.75M | +103.90% |
| LGVN | Longeveron Inc - Class A | $15.75M | +103.85% |
| CYCN | Cyclerion Therapeutics Inc | $15.74M | +103.70% |
| TPST | Tempest Therapeutics Inc | $15.35M | +98.69% |
| CLRB | Cellectar Biosciences Inc | $14.97M | +93.76% |
| APLT | Applied Therapeutics Inc | $14.86M | +92.41% |
| HOTH | Hoth Therapeutics Inc | $14.64M | +89.57% |
| LEXX | Lexaria Bioscience Corp | $14.58M | +88.71% |
| IOBT | IO Biotech Inc | $14.50M | +87.69% |
| HOOK | Hookipa Pharma Inc | $14.43M | +86.76% |
| INAB | IN8bio Inc | $14.18M | +83.56% |
| OSRH | Bellevue Life Sciences Acquisition Corp | $14.00M | +81.23% |
| ANEB | Anebulo Pharmaceuticals, Inc. Common Stock | $13.82M | +78.92% |
| BIVI | BioVie Inc - Class A | $13.35M | +72.81% |
| BLRX | Bioline Rx Ltd | $13.35M | +72.76% |
| LNAI | Lunai Bioworks Inc | $13.33M | +72.50% |
| COCP | Cocrystal Pharma Inc | $13.24M | +71.34% |
| QNCX | Quince Therapeutics Inc | $13.03M | +68.73% |
| LSB | LakeShore Biopharma Co Ltd | $13.02M | +68.56% |
| GTBP | GT Biopharma Inc | $12.33M | +59.59% |
| MBRX | Moleculin Biotech Inc | $12.33M | +59.58% |
| CALC | CalciMedica Inc | $12.31M | +59.30% |
| INTS | Intensity Therapeutics Inc | $12.30M | +59.18% |
| AIM | AIM ImmunoTech Inc. | $12.01M | +55.48% |
| KTTA | Pasithea Therapeutics Corp | $11.92M | +54.33% |
| QNRX | Quoin Pharmaceuticals Ltd | $11.92M | +54.29% |
| CTXR | Citius Pharmaceuticals Inc | $11.88M | +53.85% |
| GDTC | CytoMed Therapeutics Ltd | $11.32M | +46.55% |
| TOVX | Theriva Biologics Inc | $11.15M | +44.31% |
| CMMB | Chemomab Therapeutics Ltd | $10.93M | +41.52% |
| BCLI | Brainstorm Cell Therapeutics Inc | $10.73M | +38.95% |
| KLTOW | Klotho Neurosciences Inc Wt Exp | $10.43M | +34.98% |
| PHIO | Phio Pharmaceuticals Corp | $10.34M | +33.86% |
| XCUR | Exicure Inc | $10.33M | +33.67% |
| CVM | Cel-Sci Corp | $10.15M | +31.34% |
| MLEC | Moolec Science SA | $10.06M | +30.20% |
| KPRX | Kiora Pharmaceuticals Inc | $9.90M | +28.21% |
| BCDA | BioCardia Inc | $9.59M | +24.09% |
| MTVA | MetaVia Inc | $9.55M | +23.68% |
| VTGN | VistaGen Therapeutics Inc | $9.48M | +22.68% |
| CRIS | Curis Inc | $9.45M | +22.40% |
| TRAW | Traws Pharma Inc | $9.16M | +18.60% |
| ASBP | Aspire Biopharma Holdings Inc | $9.03M | +16.89% |
| EPIX | Essa Pharma Inc | $8.93M | +15.62% |
| SONN | Sonnet BioTherapeutics Holdings Inc | $8.92M | +15.44% |
| IMNN | Imunon Inc | $8.71M | +12.71% |
| BRTX | BioRestorative Therapies Inc | $8.66M | +12.14% |
| APRE | Aprea Therapeutics Inc | $8.48M | +9.76% |
| ADXN | Addex Therapeutics Ltd | $8.21M | +6.22% |
| SYBX | Synlogic Inc | $8.20M | +6.20% |
| IMRN | Immuron Ltd | $8.15M | +5.54% |
| ITRM | Iterum Therapeutics Plc | $8.06M | +4.36% |
| RNAZ | TransCode Therapeutics Inc | $7.97M | +3.21% |
| ERNA | Ernexa Therapeutics Inc | $7.85M | +1.59% |
| PMCB | PharmaCyte Biotech Inc | $7.57M | -1.96% |
| RVPH | Reviva Pharmaceuticals Holdings Inc | $7.49M | -3.10% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | $7.34M | -5.03% |
| AEON | AEON Biopharma Inc - Class A | $7.31M | -5.37% |
| BCAB | BioAtla Inc | $7.07M | -8.48% |
| CANF | Can-Fite Biopharma Ltd | $6.87M | -11.00% |
| KAPA | Kairos Pharma Ltd | $6.75M | -12.63% |
| XBIO | Xenetic Biosciences Inc | $6.65M | -13.89% |
| JUNS | Jupiter Neurosciences Inc | $6.48M | -16.16% |
| PCSA | Processa Pharmaceuticals Inc | $6.40M | -17.15% |
| GOVX | Geovax Labs Inc | $6.29M | -18.63% |
| CURX | Curanex Pharmaceuticals Inc | $6.11M | -20.94% |
| PPBT | Purple Biotech Ltd | $6.05M | -21.69% |
| HCWB | HCW Biologics Inc | $6.02M | -22.03% |
| APM | Aptorum Group Limited Class A Ordinary Shares | $6.01M | -22.16% |
| ACXP | Acurx Pharmaceuticals Inc | $5.93M | -23.22% |
| CVKD | Cadrenal Therapeutics Inc | $5.89M | -23.74% |
| PULM | Pulmatrix Inc | $5.73M | -25.77% |
| EVGN | Evogene Ltd | $5.64M | -26.94% |
| APVO | Aptevo Therapeutics Inc | $5.50M | -28.78% |
| CDIO | Cardio Diagnostics Holdings Inc | $5.30M | -31.42% |
| SILO | SILO Pharma Inc | $5.29M | -31.53% |
| DRMA | Dermata Therapeutics Inc | $5.23M | -32.31% |
| LIMN | Liminatus Pharma Inc | $5.14M | -33.48% |
| TCRT | Alaunos Therapeutics Inc | $5.07M | -34.42% |
| BGMS | Bio Green Med Solution Inc | $5.00M | -35.31% |
| NCNA | NuCana plc | $4.99M | -35.39% |
| TTNP | Titan Pharmaceuticals Inc (de) | $4.91M | -36.44% |
| CLGN | CollPlant Biotechnologies Ltd New | $4.80M | -37.91% |
| ALZN | Alzamend Neuro Inc | $4.68M | -39.42% |
| GNPX | Genprex Inc | $4.44M | -42.52% |
| CASI | CASI Pharmaceuticals Inc | $4.27M | -44.78% |
| ENTO | Entero Therapeutics, Inc. Common Stock | $4.26M | -44.80% |
| REVB | Revelation Biosciences Inc | $4.26M | -44.85% |
| MBIO | Mustang Bio Inc | $4.25M | -44.94% |
| ADIL | Adial Pharmaceuticals Inc | $4.24M | -45.10% |
| ENVB | Enveric Biosciences Inc | $4.15M | -46.24% |
| CNSP | Cns Pharmaceuticals Inc | $4.14M | -46.43% |
| SXTP | 60 Degrees Pharmaceuticals Inc | $4.09M | -47.09% |
| SNGX | Soligenix Inc | $3.91M | -49.35% |
| PBM | Psyence Biomedical Ltd | $3.76M | -51.29% |
| CELZ | Creative Medical Technology Holdings Inc | $3.70M | -52.14% |
| GLMD | Galmed Pharmaceuticals Ltd | $3.38M | -56.25% |
| XRTX | XORTX Therapeutics Inc | $3.34M | -56.74% |
| FBLG | FibroBiologics Inc | $3.18M | -58.84% |
| SLXN | Silexion Therapeutics Corp | $3.11M | -59.73% |
| SPRC | SciSparc Ltd | $3.05M | -60.57% |
| BDRX | Biodexa Pharmaceuticals Plc | $2.98M | -61.40% |
| AFMD | Affimed N.V. | $2.98M | -61.48% |
| ENSC | Ensysce Biosciences Inc | $2.88M | -62.77% |
| ARTL | Artelo Biosciences Inc | $2.75M | -64.45% |
| GRI | GRI Bio Inc | $2.57M | -66.76% |
| ONCO | Onconetix Inc | $2.54M | -67.13% |
| PPCB | Propanc Biopharma Inc | $2.50M | -67.62% |
| VIVS | VivoSim Labs Inc | $2.47M | -68.04% |
| OGEN | Oragenics Inc | $2.45M | -68.28% |
| NBY | Stablecoin Development Corp | $2.40M | -68.87% |
| NTBL | Notable Labs Inc Ord | $2.39M | -69.00% |
| BBLG | Bone Biologics Corp | $2.23M | -71.18% |
| AZTR | Azitra Inc | $2.22M | -71.22% |
| MTNB | Matinas Biopharma Holdings Inc | $2.18M | -71.75% |
| CLSD | Clearside Biomedical, Inc. Common Stock | $2.15M | -72.22% |
| CMND | Clearmind Medicine Inc | $2.12M | -72.62% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | $2.09M | -72.97% |
| CLDI | Calidi Biotherapeutics Inc | $1.99M | -74.18% |
| ONCT | Oncternal Therapeutics Inc | $1.56M | -79.82% |
| VRAX | Virax Biolabs Group Ltd - Class A | $1.52M | -80.33% |
| ABP | Abpro Holdings, Inc Common Stock | $1.43M | -81.53% |
| JAGX | Jaguar Health Inc | $1.34M | -82.61% |
| ZVSA | ZyVersa Therapeutics Inc | $1.03M | -86.67% |
| LYRA | Lyra Therapeutics Inc | $927198.36 | -88.00% |
| SCNI | Scinai Immunotherapeutics Ltd | $912143.15 | -88.19% |
| TNFA | TNF Pharmaceuticals Inc | $551031.39 | -92.87% |
| PTIX | Protagenic Therapeutics Inc | $503648.74 | -93.48% |
| SLRX | Decoy Therapeutics Inc | $446853.12 | -94.22% |
| ELAB | PMGC Holdings Inc | $221376.00 | -97.13% |
| CDT | CDT Equity Inc | $110551.31 | -98.57% |
| ADTX | Aditxt Inc | $98471.97 | -98.73% |